Mariusz Ignatowicz, PwC healthcare sector leader for CEE, discusses the funding of the Polish healthcare ecosystem and the need to find an alternative payer in the long-term Additionally, he highlights PwC’s services and the overall requirement for data to be taken into more consideration in Polish healthcare to ensure accurate and precise decisions.
How has PwC adjusted to the shift in Polish healthcare over the last few years?
"The development of healthcare and pharmaceutical services is highly restricted due to the country being forced to only have access to the public payers and there is definably a lack of alternative sources of financing."
